Table for the 2 triples with object "The FDA notes that this is a weak CYP2D6 inhibitor for in vivo studies in it most recent guidance document. See Table 6, p. 23" sorted by label

SubjectPredicate
?:evidence_1253?:content
?:evidence_1985?:content